CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
Livongo Health System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02956642
NCT02956642N/ACompleted
CompareCT.gov

Study to Understand Gaining Access to Blood Glucose Records (SUGAR), A Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control

University of California, San Francisco·interventional·Posted Nov 7, 2016·Updated Apr 30, 2025

In Brief

A clinical study evaluating Livongo Health System and iHealth Glucose Meter for Diabetes Mellitus. Completed, enrolled 84 participants across 1 site.

Detailed Summary

This study is a two-arm randomized controlled trial in which participants will receive either the Livongo Health system or iHealth glucose meter for measuring their blood glucose. The study hypothesizes the use of the Livongo Health system results in a greater improvement in A1c compared to standard blood glucose monitoring, as demonstrated by the iHealth Bluetooth-enabled glucose meter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
CollaboratorsLivongo Health

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 7, 2016
Enrollment StartNov 14, 2018
Primary CompletionJan 17, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.7 years ago

Interventions

Livongo Health Systemdevice

Participants will be asked to use the Livongo Health System to manage their blood glucose.

iHealth Glucose Meterdevice

Participants will be asked to use the iHealth Glucose Meter to take blood glucose measurements.